Myocardial perfusion SPECT with dipyridamole stress test in cardiac syndrome X

NuklearMedizin

Volumn 45, Issue 3, 2006, Pages 111-114

  Czepczyński, Rafal ^a,b   Smolarek, I ^a   Rogacka, D ^a   Kazmierczak M ^a   Wysocki, Henryk ^a   Sowinski J ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b Nuclear Medicine Unit   (Poland)

Author keywords

99mTc Sestamibi; Cardiac syndrome X; Coronary angiography; Dipyridamole; SPEQ

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; DIPYRIDAMOLE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY; ELECTROCARDIOGRAM; EXERCISE; EXERCISE TEST; FEMALE; HEART MUSCLE PERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; RATING SCALE; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYNDROME X; THORAX PAIN;

EID: 33745887482     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1625328     Document Type: Article

References (29)

1. Albertsson P A, Emanuelsson H, Milsom I. Beneficial effect of treatment with transdermal estradiol-17-beta on exercise-induced angina and ST segment depression in syndrome X. Int J Cardiol 1996; 54: 13-20.
2. Araujo W, DePuey EG, Kamran M et al. Artifactual reverse distribution pattern in myocardial perfusion SPECT with technetium-99m sestamibi. J Nucl Cardiol 2000; 7: 633-8.
3. Bellamy MF, Goodfellow J, Tweddel AC et al. Syndrome X and endothelial dysfunction. Cardiovasc Res 1998; 40: 410-7.
4. Cannon RO. The sensitive heart. A syndrome of abnormal cardiac pain perception. JAMA 1995, 273, 11883-7.
5. Cannon RO, Camici PG, Epstein S. Pathophysiological dilemma of syndrome X. Circulation 1992; 85: 883-92.
6. Cavusoglu Y, Entok E, Timuralp B et al. Regional distribution and extent of perfusion abnormalities, thallium-201 SPECT imaging in patients with cardiac syndrome X. Can J Cardiol 2005; 21: 57-62.
7. Cerqueira MD, Weissman NJ, Dilsizian V et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002; 105: 539-42.
8. Crea F, Lanza GA. Angina pectoris and normal coronary arteries: cardiac syndrome X. Heart 2004; 90: 457-63.
9. Egashira K, Inou T, Hirooka Y et al. Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. N Eng J Med 1993; 328: 192-6.
10. Froher O, Nielsen LA, Bak P et al. Pain perception and brain evoked potentials in patients with angina despite normal coronary angiograms. Heart 1996; 75: 436-41.
11. 201Tl perfusion during exercise in patients with angina pectoris and normal coronary angiograms. J Nucl Cardiol 2000; 7: 97-102.
12. Inobe Y, Kugiyama K, Morita E et al. Role ofadenosine in pathogenesis of syndrome X: assessment with coronary hemodynamic measurments and thallium-201 myocardial single-photon emission computer tomography. J Am Coll Cardiol 1996; 28: 890-6.
13. Kaski JC, Elliott PM, Salomone O et al. Concentration of circulation plasma endothelin in patients with angina and normal coronary angiograms. Br Heart J 1995; 74: 620-4.
14. Kemp H. Left ventricular function in patients with the anginal syndrome and normal coronary arteriograms. Am J Cardiol 1973; 32: 375-6
15. Kemp HG, Kronmal RA, Vliestra RE et al. Seven years survival of patients with normal or near normal coronary angiograms: a CASS Registry study. J Am Coll Cardiol 1986; 7: 479-83.
16. 123I- metaiodobenzylguanidine myocardial scintigraphy. Circulation 1997; 96: 821-6.
17. Legrand V, Hodgson JM, Bates ER et al. Abnormal coronary flow reserve and abnormal radionuclide exercise test results in patients with normal coronary angiograms. J Am Coll Cardiol 1985; 6: 1245-53.
18. Masci PG, Laclaustra M, Lara JG et al. Brachial artery flow-mediated dilation and myocardial perfusion in patients with cardiac syndrome X. Am J Cardiol 2005; 95: 1478-80.
19. Mazeika P, Nihoyannopoulos P, Joshi J et al. Uses and limitations of high-dose dipyridamole stress echocardiography for evaluation of coronary artery disease. Br Heart J 1992; 67: 144-9.
20. Nihoyannopoulos R, Kaski JC, Crake T et al. Absence of myocardial dysfunction during stress in patients with syndrome X. J Am Coll Cardiol 1991; 18: 1463-70.
21. Panting JR, Gatehouse PD, Guang-Zhong Y et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 2002; 346: 1948-53.
22. 99mTc-MIBl single photon emission computed tomography in the detection of coronary artery disease. Am J Cardiol 1991; 67: 350-5.
23. Rogacka D, Guzik P, Kazmierczak M et al. Cardiac syndrome X. The role of ECG Holler monitoring, dipyridamole stress echocardiography and technetium SPECT imaging. Kardiol Pol 1999; 51: 293-9.
24. Rosano GMC, Collins P, Kaski JC et al. Syndrome X in women is associated with oestrogen deficiency. Eur Heart J 1995; 15: 610-4.
25. Rosano GM, Kaski JC, Arie S et al. Failure to demonstrate myocardial ischemia in patients with angina and normal coronary arteries. Evaluation by continuous coronary sinus pH monitoring and lactate metabolism. Eur Heart J 1996; 17: 1175-80.
26. Rosano GM, Ponikowski P, Adamopoulos S et al. Abnormal autonomic control of cardiovascular system in syndrome X. Am J Cardiol 1994; 73: 1174-9.
27. Turiel M, Galassi AR, Glazier JJ et al. Pain treshold and tolerance in women with syndrome X and women with stable angina pectoris. Am J Cardiol 1987; 6: 503-7.
28. Tweddel AC, Martin W, Hutton I. Thallium scans in syndrome X. Br Heart J 1992; 68: 48-50.
29. Yoshio H, Shimizu M, Kita Y et al. Effect of short term aminophylline administration on cardiac functional reserve in patients with syndrome X. J Am Coll Cardiol 1995; 25: 1547-51.